Thibault Joseph William Jacques Dit Lapierre

7PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Basic pharmacologyNanotoxicology, health and safetyMolecular medicineCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2026
Piperazine and Morpholine Protoporphyrin IX Derivatives Intensify Biomolecules Oxidation and Phototoxicity in Triple-Negative Breast Cancer.

|Aug 04, 2026
Identification of a Benzenesulfonylpiperazine Derivative With In Vivo Efficacy Against Visceral Leishmaniasis.

|Aug 29, 2025
Hit-to-Lead Studies of Pyrazinylpiperazines against Visceral Leishmaniasis: Pharmacokinetic Profile and In Vivo Efficacy of Potent Compounds against Leishmania infantum.

Thibault Joseph William Jacques Dit Lapierre, Mariza Gabriela Faleiro de Moura Lodi Cruz, Gisele Barbosa

|Jul 06, 2024
Modulation of the Meisenheimer complex metabolism of nitro-benzothiazinones by targeted C-6 substitution.

François Keiff, Freddy A Bernal, Melanie Joch

|May 08, 2024
New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease.

Silvane Maria Fonseca Murta, Pedro Augusto Lemos Santana, Thibault Joseph William Jacques Dit Lapierre

|Sep 29, 2023
Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.

Mariana Laureano de Souza, Thibault Joseph William Jacques Dit Lapierre, Gabriel Vitor de Lima Marques

Pageof 2

Frequent Collaborators

2 joint publications

François Keiff

2 joint publications

Freddy A Bernal

2 joint publications

Florian Kloss

2 joint publications

Mariana Laureano de Souza